Trials / Unknown
UnknownNCT04440618
Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study's aim is to determinate the prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy in a locally advanced stages treated population of oropharyngeal cancer. Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies published on the subject suggest an increased risk of development of OSAHS for these patients.
Conditions
Timeline
- Start date
- 2020-07-30
- Primary completion
- 2021-05-30
- Completion
- 2021-06-30
- First posted
- 2020-06-19
- Last updated
- 2021-01-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04440618. Inclusion in this directory is not an endorsement.